PRENATAL METHAMPHETAMINE EXPOSURE AND SCHOOL AGE OUTCOME

产前甲基苯丙胺暴露和学龄结果

• 批准号: 8174512
• 负责人: LYNNE T SMITH
• 金额: $ 13.36万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8174512
• 关键词: Area; Certificate of Confidentiality; Child; Computer Retrieval of Information on Scientific Projects Database; Confidentiality; Development; Distress; Drug usage; Family; Funding; Grant; Institution; Interviewer; Methamphetamine; Outcome; Parents; Participant; Procedures; Research; Research Personnel; Resources; Risk; School-Age Population; Source; Study Subject; United States National Institutes of Health; Vulnerable Populations; fetal methamphetamine exposure; minimal risk

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a moderate risk study with the potential to benefit METH-exposed children and their families. Although this study poses no more than minimal risk to the participants, the proposal is best classified as a moderate risk study because we are studying a vulnerable population (methamphetamine- exposed children) The risks to the subjects are in the areas of discomfort with study procedures. Children may become distressed or bored during developmental assessments and parents may become distressed by sensitive questions. These risks have been rarely observed in similar studies using the same procedures primarily becaues of the positive relationship already established between subjects and study examiners and interviewers during the first 3 years of the study. Loss of confidentiality is another risk to participants. Numerous safeguards are in place to minimize this risk and a Federal Certificate of Confidentiality protects the study from disclosing illegal drug use against the wishes of the participants.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项中等风险研究，有可能使接触甲基苯丙胺的儿童及其家庭受益。 尽管本研究对参与者的风险最小，但该提案最好归类为中等风险研究，因为我们研究的是弱势人群（甲基苯丙胺暴露儿童）。受试者的风险在于研究程序的不适。孩子们可能会在发展评估过程中感到沮丧或无聊，父母可能会因为敏感问题而感到沮丧。在使用相同程序的类似研究中很少观察到这些风险，主要是因为在研究的前3年期间，受试者与研究检查者和访谈者之间已经建立了积极的关系。 失去保密性是参与者面临的另一个风险。 采取了许多保护措施以最大限度地降低这种风险，联邦保密证书可保护研究免于披露违反受试者意愿的非法药物使用。